I like the risk-reward here for traders.
All of the index charts remain in short-term uptrends and above their 50 DMAs.
Let's visit with the charts and indicators to get another perspective.
Why has this stock strengthened?
We review Acadia Pharmaceuticals, The Medicines Company, and Flexion Therapeutics.
Have shares of this leading health benefits company bottomed?
After a sprint higher in the IT company's shares in recent days, traders and investors might do well to wait for a temporary pullback to pick up the stock.
Let's look at the indicators and charts as we get to overbought, while breadth is healthy but showing signs of concern and the banks are on fire.
Let's take a look at the charts.
AIMT lacks a strong and developed base, so only small long positions should be bought.